Finding optimal drug target sites in parasite pathogens
- PMID: 36564249
- DOI: 10.1016/j.pt.2022.12.003
Finding optimal drug target sites in parasite pathogens
Abstract
Benns et al. have recently combined a chemoproteomic profiling method with a CRISPR-based gene-editing method to identify chemically targetable residues essential for fitness in the parasite Toxoplasma gondii. The result is a strategy that enables rapid discovery of new drug targets to combat T. gondii and other related parasites.
Keywords: CRISPR-mediated gene editing; Plasmodium falciparum; Toxoplasma gondii; activity-based protein profiling; chemoproteomics; cysteine reactivity.
Copyright © 2022. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of interests The author declares no competing interests.
Comment on
-
CRISPR-based oligo recombineering prioritizes apicomplexan cysteines for drug discovery.Nat Microbiol. 2022 Nov;7(11):1891-1905. doi: 10.1038/s41564-022-01249-y. Epub 2022 Oct 20. Nat Microbiol. 2022. PMID: 36266336 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources